Share of TB treatment outcomes of MDR RR conventional regimen India 2007-2017

Published by A. Minhas, Jul 12, 2023
In 2017, the multiple drug resistant rifampicin resistant regimen saw a 48 percent success rate. The death rate and lost to follow up stood at 19 and 18 percent respectively, while the failure rate of the drug was two percent during the same time period.

Share of TB treatment outcomes of MDR RR conventional regimen in India from 2007 to 2017

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2020

Region

India

Survey time period

2007 to Q2 2017

Supplementary notes

MDR - multi resistant drug treatment
RR - rifampicin resistant
*Results of 2017 are till the second quarter

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Tuberculosis in India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Tuberculosis in India

Overview

3

Notifications

6

Co-morbidities

3

Finance

3

Prevention

4

Treatment outcome

5

Outlook - predicted values until 2023

4

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Tuberculosis in IndiaTuberculosisRespiratory disease in the UKCommunicable diseases in the UK
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu